Form 4: John E. Imhoff Reports Acquisition of Stock Options and Warrants in Guided Therapeutics Inc.
SEC Form 4 Filing
Director John E. Imhoff reports the acquisition of stock options and warrants in Guided Therapeutics Inc.
Summary
- John E. Imhoff, a director and 10% owner of Guided Therapeutics Inc. (GTHP), filed a Form 4 detailing changes in beneficial ownership.
- On July 9, 2024, Imhoff acquired stock options for 100,000 shares at an exercise price of $0.12, with vesting occurring over time.
- As of the reported transaction, Imhoff directly owns 250,000 warrants.
- On July 31, 2024, in conjunction with a $25,000 note payable to Mr. Imhoff, the Company also issued four-year warrants to purchase an aggregate of 25,000 shares of Common Stock at $0.25 per share.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of insider transactions. The acquisition of options and warrants could be interpreted as a positive sign, but it's not definitive.
Positives
- The acquisition of stock options and warrants by a director could be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key individuals within a company.
Related Party Transactions
- The company issued a $25,000 note payable to Mr. Imhoff, a director, and issued warrants in conjunction with the note.
Stakeholder Impact
- The transactions could influence shareholder perception of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 07/09/2024 | Date of earliest transaction; acquisition of stock options, one-fourth of the shares subject to the award vested. |
| 07/08/2027 | Date when the remaining shares of the stock options will be fully vested. |
| 07/31/2024 | Date the Company issued a $25,000 note payable to Mr. Imhoff and issued warrants to purchase 25,000 shares of Common Stock. |
| 07/30/2028 | Expiration date of the warrants. |
| 09/06/2024 | Date of the report. |
Keywords
Form 4, beneficial ownership, Guided Therapeutics Inc, GTHP, stock options, warrants, John E. Imhoff, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.